Evidence-based treatment of anxiety in patients with cancer

Journal of Clinical Oncology

Volumn 30, Issue 11, 2012, Pages 1197-1205

  Traeger, Lara ^a   Greer, Joseph A ^a   Fernandez Robles, Carlos ^a   Temel, Jennifer S ^a   Pirl, William F ^a  

^a MASSACHUSETTS GENERAL HOSPITAL CANCER CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIDEPRESSANT AGENT; ANTIEMETIC AGENT; ANTINEOPLASTIC AGENT; ANXIOLYTIC AGENT; BENZODIAZEPINE DERIVATIVE; BUSPIRONE; CITALOPRAM; DESIPRAMINE; ESCITALOPRAM; FLUOXETINE; FLUVOXAMINE; GABAPENTIN; GLUCOCORTICOID; LORAZEPAM; MIRTAZAPINE; NEUROLEPTIC AGENT; NICOTINE; OLANZAPINE; OMEPRAZOLE; OPIATE; PAROXETINE; QUETIAPINE; SEDATIVE AGENT; SEROTONIN NORADRENALIN REUPTAKE INHIBITOR; SEROTONIN UPTAKE INHIBITOR; SERTRALINE; TAMOXIFEN; TRICYCLIC ANTIDEPRESSANT AGENT; UNINDEXED DRUG; VENLAFAXINE;

ACUTE STRESS DISORDER; AFFECTIVE NEUROSIS; AGORAPHOBIA; ANOREXIA; ANXIETY DISORDER; BEHAVIOR; BEHAVIOR DISORDER; BRACHYTHERAPY; CANCER CHEMOTHERAPY; CANCER PALLIATIVE THERAPY; CANCER PATIENT; CANCER RADIOTHERAPY; CLINICAL PRACTICE; CLINICAL PROTOCOL; CLINICAL TRIAL (TOPIC); COGNITIVE DEFECT; COGNITIVE THERAPY; COPING BEHAVIOR; DELIRIUM; DEPRESSION; DIAGNOSTIC TEST; DISEASE COURSE; DRUG EFFICACY; DRUG MEGADOSE; DRUG METABOLISM; DRUG OVERDOSE; DRUG SAFETY; DRUG TOLERABILITY; DSM-IV; EVIDENCE BASED MEDICINE; GENERALIZED ANXIETY DISORDER; HEART ARRHYTHMIA; HUMAN; HYPERCALCEMIA; HYPOGLYCEMIA; INSOMNIA; LUNG EMBOLISM; MAJOR DEPRESSION; META ANALYSIS; NAUSEA; NEOPLASM; OBSESSIVE COMPULSIVE DISORDER; ONCOLOGY; OUTCOME ASSESSMENT; PANIC; PHOBIA; POSTTRAUMATIC STRESS DISORDER; PREVALENCE; PRIORITY JOURNAL; PSYCHOPHARMACOTHERAPY; PSYCHOSOCIAL CARE; PSYCHOTHERAPY; QT PROLONGATION; RANDOMIZED CONTROLLED TRIAL (TOPIC); REVIEW; RISK FACTOR; SOCIAL PHOBIA; SOMATIZATION; SPECIFIC PHOBIA; SYMPTOM; SYSTEMATIC REVIEW; TREATMENT INDICATION; TREATMENT OUTCOME; VOMITING; WITHDRAWAL SYNDROME; ANXIETY; EVIDENCE BASED PRACTICE; PSYCHOLOGICAL ASPECT;

ANXIETY; ANXIETY DISORDERS; EVIDENCE-BASED PRACTICE; HUMANS; NEOPLASMS; PREVALENCE;

EID: 84861569893     PISSN: 0732183X     EISSN: 15277755     Source Type: Journal    
DOI: 10.1200/JCO.2011.39.5632     Document Type: Review

References (104)

1. Brintzenhofe-Szoc KM, Levin TT, Li Y, et al: Mixed anxiety/depression symptoms in a large cancer cohort: Prevalence by cancer type. Psychosomatics 50:383-391, 2009
2. Mitchell AJ, Chan M, Bhatti H, et al: Prevalence of depression, anxiety, and adjustment disorder in oncological, haematological, and palliative-care settings: A meta-analysis of 94 interview-based studies. Lancet Oncol 12:160-174, 2011
3. Latini DM, Hart SL, Knight SJ, et al: The relationship between anxiety and time to treatment for patients with prostate cancer on surveillance. J Urol 178:826-831, 2007
4. Andrykowski MA: The role of anxiety in the development of anticipatory nausea in cancer chemotherapy: A review and synthesis. Psychosom Med 52:458-475, 1990
5. Greer JA, Pirl WF, Park ER, et al: Behavioral and psychological predictors of chemotherapy adherence in patients with advanced non-small cell lung cancer. J Psychosom Res 65:549-552, 2008
6. Brown LF, Kroenke K, Theobald DE, et al: The association of depression and anxiety with health-related quality of life in cancer patients with depression and/or pain. Psychooncology 19:734-741, 2010
7. American Psychiatric Association: Diagnostic and Statistical Manual of Mental Disorders, Fourth Edition, Text Revision. Washington, DC, American Psychiatric Association, 2000
8. King-Kallimanis B, Gum AM, Kohn R: Comorbidity of depressive and anxiety disorders for older Americans in the national comorbidity survey-replication. Am J Geriatr Psychiatry 17:782-792, 2009
9. Kangas M, Henry JL, Bryant RA: The course of psychological disorders in the 1st year after cancer diagnosis. J Consult Clin Psychol 73:763-768, 2005
10. Gurevich M, Devins GM, Rodin GM: Stress response syndromes and cancer: Conceptual and assessment issues. Psychosomatics 43:259-281, 2002
11. Fröjd C, Lampic C, Larsson G, et al: Patient attitudes, behaviours, and other factors considered by doctors when estimating cancer patients' anxiety and desire for information. Scand J Caring Sci 21: 523-529, 2007
12. Fallowfield L, Ratcliffe D, Jenkins V, et al: Psychiatric morbidity and its recognition by doctors in patients with cancer. Br J Cancer 84:1011-1015, 2001
13. Jacobsen PB, Jim HS: Psychosocial interventions for anxiety and depression in adult cancer patients: Achievements and challenges. CA Cancer J Clin 58:214-230, 2008
14. Mitchell AJ: Pooled results from 38 analyses of the accuracy of distress thermometer and other ultrashort methods of detecting cancer-related mood disorders. J Clin Oncol 25:4670-4681, 2007
15. Zigmond AS, Snaith RP: The hospital anxiety and depression scale. Acta Psychiatr Scand 67:361-370, 1983
16. Luckett T, Butow PN, King MT, et al: A review and recommendations for optimal outcome measures of anxiety, depression and general distress in studies evaluating psychosocial interventions for English-speaking adults with heterogeneous cancer diagnoses. Support Care Cancer 18:1241-1262, 2010
17. Meltzer-Brody SE, Churchill E, Davidson JR: Derivation of the SPAN: A brief diagnostic screening test for post-traumatic stress disorder. Psychiatry Res 88:63-70, 1999
18. Spitzer R, Kroenke K, Williams J: Validation and utility of a self-report version of PRIMEMD: The PHQ Primary Care Study. JAMA 282:1737-1744, 1999
19. Spitzer RL, Kroenke K, Williams JB, et al: A brief measure for assessing generalized anxiety disorder: The GAD-7. Arch Intern Med 166:1092-1097, 2006
20. Stiefel F, Razavi D: Common psychiatric disorders in cancer patients: II. Anxiety and acute confusional states. Support Care Cancer 2:233-237, 1994
21. Green BL, Rowland JH, Krupnick JL, et al: Prevalence of posttraumatic stress disorder in women with breast cancer. Psychosomatics 39:102-111, 1998
22. Jacobsen PB, Sadler IJ, Booth-Jones M, et al: Predictors of posttraumatic stress disorder symptomatology following bone marrow transplantation for cancer. J Consult Clin Psychol 70:235-240, 2002
23. Kangas JL, Bryant RA: Predictors of post-traumatic stress disorder following cancer. Health Psychol 24:579-585, 2005
24. Spencer R, Nilsson M, Wright A, et al: Anxiety disorders in advanced cancer patients: Correlates and predictors of end-of-life outcomes. Cancer 116:1810-1819, 2010
25. Lichtenthal WG, Nilsson M, Zhang B, et al: Do rates of mental disorders and existential distress among advanced stage cancer patients increase as death approaches? Psychooncology 18:50-61, 2009
26. Fleishman S, Lavin M, Sattler M, et al: Antiemetic-induced akathisia in cancer patients. Am J Psychiatry 151:763-765, 1994
27. Dudgeon DJ, Lertzman M: Dyspnea in the advanced cancer patient. J Pain Symptom Manage 16:212-219, 1998
28. Plotnik AN, Carney P, Schweder P, et al: Seizures initially diagnosed as panic attacks: Case series. Aust N Z J Psychiatry 43:878-882, 2009
29. Brown LF, Kroenke K: Cancer-related fatigue and its associations with depression and anxiety: A systematic review. Psychosomatics 50:440-447, 2009
30. So WK, Marsh G, Ling WM, et al: The symptom cluster of fatigue, pain, anxiety, and depression and the effect on the quality of life of women receiving treatment for breast cancer:Amulticenter study. Oncol Nurs Forum 36:E205-E214, 2009
31. Delgado-Guay M, Parsons HA, Li Z, et al: Symptom distress in advanced cancer patients with anxiety and depression in the palliative care setting. Support Care Cancer 17:573-579, 2009
32. Du-Quiton J, Wood PA, Burch JB, et al: Actigraphic assessment of daily sleep-activity pattern abnormalities reflects self-assessed depression and anxiety in outpatients with advanced non-small cell lung cancer. Psychooncology 19:180-189, 2010
33. Vlaeyen JW, Linton SJ: Fear-avoidance and its consequences in chronic musculoskeletal pain: A state of the art. Pain 85:317-332, 2000
34. den Hollander M, de Jong JR, Volders S, et al: Fear reduction in patients with chronic pain: A learning theory perspective. Expert Rev Neurother 10:1733-1745, 2010
35. Trask PC, Paterson AG, Griffith KA, et al: Cognitive-behavioral intervention for distress in patients with melanoma: Comparison with standard medical care and impact on quality of life. Cancer 98:854-864, 2003
36. Evans RL, Connis RT: Comparison of brief group therapies for depressed cancer patients receiving radiation treatment. Public Health Rep 110: 306-311, 1995
37. Savard J, Simard S, Ivers H, et al: Randomized study on the efficacy of cognitive-behavioral therapy for insomnia secondary to breast cancer, part I: Sleep and psychological effects. J Clin Oncol 23:6083-6096, 2005
38. Espie CA, Fleming L, Cassidy J, et al: Randomized controlled clinical effectiveness trial of cognitive behavior therapy compared with treatment as usual for persistent insomnia in patients with cancer. J Clin Oncol 26:4651-4658, 2008
39. Dolbeault S, Cayrou S, Brédart A, et al: The effectiveness of a psycho-educational group after early-stage breast cancer treatment: Results of a randomized French study. Psychooncology 18:647-656, 2009
40. Moorey S, Cort E, Kapari M, et al: A cluster randomized controlled trial of cognitive behaviour therapy for common mental disorders in patients with advanced cancer. Psychol Med 39:713-723, 2009
41. Telch CF, Telch MJ: Group coping skills instruction and supportive group therapy for cancer patients: A comparison of strategies. J Consult Clin Psychol 54:802-808, 1986
42. Greer S, Moorey S, Baruch JD, et al: Adjuvant psychological therapy for patients with cancer: A prospective randomised trial. BMJ 304:675-680, 1992
43. Strong V, Waters R, Hibberd C, et al: Management of depression for people with cancer (SMaRT oncology 1): A randomised trial. Lancet 372:40-48, 2008
44. Bindemann S, Soukop M, Kaye SB: Randomised controlled study of relaxation training. Eur J Cancer 27:170-174, 1991
45. Petersen RW, Quinlivan JA: Preventing anxiety and depression in gynaecological cancer: A randomised controlled trial. Br J Obstet Gynaecol 109:386-394, 2002
46. Cheung YL, Molassiotis A, Chang AM: The effect of progressive muscle relaxation training on anxiety and quality of life after stoma surgery in colorectal cancer patients. Psychooncology 12:254-266, 2003
47. Leon-Pizarro C, Gich I, Barthe E, et al: A randomized trial of the effect of training in relaxation and guided imagery techniques in improving psychological and quality-of-life indices for gynecologic and breast brachytherapy patients. Psychooncology 16:971-979, 2007
48. Burish TG, Lyles JN: Effectiveness of relaxation training in reducing adverse reactions to cancer chemotherapy. J Behav Med 4:65-78, 1981
49. Burish TG, Carey MP, Krozely MG, et al: Conditioned side effects induced by cancer chemotherapy: Prevention through behavioral treatment. J Consult Clin Psychol 55:42-48, 1987
50. Arakawa S: Relaxation to reduce nausea, vomiting, and anxiety induced by chemotherapy in Japanese patients. Cancer Nurs 20:342-349, 1997
51. Jacobsen PB, Meade CD, Stein KD, et al: Efficacy and costs of two forms of stress management training for cancer patients undergoing chemotherapy. J Clin Oncol 20:2851-2862, 2002
52. Decker TW, Cline-Elsen J, Gallagher M: Relaxation therapy as an adjunct in radiation oncology. J Clin Psychol 48:388-393, 1992
53. Elsesser K, van Berkel M, Sartory G: The effects of anxiety management training on psychological variables and immune parameters in cancer patients: A pilot study. Behav Cognit Psychother 22:13-23, 1994
54. Hidderley M, Holt M: A pilot randomized trial assessing the effects of autogenic training in early stage cancer patients in relation to psychological status and immune system responses. Eur J Oncol Nursing 8:61-65, 2004
55. White VM, Macvean ML, Grogan S, et al: Can a tailored telephone intervention delivered by volunteers reduce the supportive care needs, anxiety and depression of people with colorectal cancer? A randomised controlled trial. Psychooncology [epub ahead of print on July 18, 2011]
56. Spiegel D, Bloom JR, Yalom I: Group support for patients with metastatic cancer: A randomized outcome study. Arch Gen Psychiatry 38:527-533, 1981
57. McQuellon RP, Wells M, Hoffman S, et al: Reducing distress in cancer patients with an orientation program. Psychooncology 7:207-217, 1998
58. Thomas R, Daly M, Perryman B, et al: Forewarned is forearmed: Benefits of preparatory information on video cassette for patients receiving chemotherapy or radiotherapy - A randomised controlled trial. Eur J Cancer 36:1536-1543, 2000
59. Katz MR, Irish JC, Devins GM: Development and pilot testing of a psychoeducational intervention for oral cancer patients. Psychooncology 13:642-653, 2004
60. Ali NS, Khalil HZ: Effect of psychoeducational intervention on anxiety among Egyptian bladder cancer patients. Cancer Nurs 12:236-242, 1989
61. Jacobs C, Ross RD, Walker IM, et al: Behavior of cancer patients: A randomized study of the effects of education and peer support groups. Am J Clin Oncol 6:347-353, 1983
62. Holland JC, Morrow GR, Schmale A, et al: A randomized clinical trial of alprazolam versus progressive muscle relaxation in cancer patients with anxiety and depressive symptoms. J Clin Oncol 9:1004-1011, 1991
63. Wald TG, Kathol RG, Noyes R Jr, et al: Rapid relief of anxiety in cancer patients with both alprazolam and placebo. Psychosomatics 34:324-332, 1993
64. Clerico M, Bertetto O, Morandini MP, et al: Antiemetic activity of oral lorazepam in addition to methylprednisolone and metoclopramide in the prophylactic treatment of vomiting induced by cisplatin: A double-blind, placebo-controlled study with crossover design. Tumori 79:119-122, 1993
65. González Barón M, Chacón JI, García Girón C, et al: Antiemetic regimens in outpatients receiving cisplatin and non-cisplatin chemotherapy: A randomized trial comparing high-dose metoclopramide plus methylprednisolone with and without lorazepam. Acta Oncol 30:623-627, 1991
66. Holland JC, Romano SJ, Heiligenstein JH: A controlled trial of fluoxetine and desipramine in depressed women with advanced cancer. Psychooncology 7:291-300, 1998
67. Razavi D, Allilaire JF, Smith M, et al: The effect of fluoxetine on anxiety and depression symptoms in cancer patients. Acta Psychiatr Scand 94: 205-210, 1996
68. Musselman DL, Lawson DH, Gumnick JF, et al: Paroxetine for the prevention of depression induced by high-dose interferon alfa. N Engl J Med 344:961-966, 2001
69. Musselman DL, Somerset WI, Guo Y, et al: A double-blind, multicenter, parallel-group study of paroxetine, desipramine, or placebo in breast cancer patients (stages I, II, III, and IV) with major depression. J Clin Psychiatry 67:288-296, 2006
70. Stockler MR, O'Connell R, Nowak AK, et al: Effect of sertraline on symptoms and survival in patients with advanced cancer, but without major depression: A placebo-controlled double-blind randomised trial. Lancet Oncol 8:603-612, 2007
71. Cankurtaran ES, Ozalp E, Soygur H, et al: Mirtazapine improves sleep and lowers anxiety and depression in cancer patients: Superiority over imipramine. Support Care Cancer 16:1291-1298, 2008
72. Moyer A, Sohl SJ, Knapp-Oliver SK: Characteristics and methodological quality of 25 years of research investigating psychosocial interventions for cancer patients. Cancer Treat Rev 35:475-484, 2009
73. Jacobsen PB, Donovan KA, Swaine ZN, et al: Management of anxiety and depression in adult cancer patients: Toward an evidence-based approach, in Chang AE, Ganz PA, Hayes DF, et al (eds): Oncology: An Evidence-Based Approach. New York, NY, Springer-Verlag, 2006, pp 1552-1579
74. Kennedy SH, Lam RW, Sagar VP, et al: Canadian Network for Mood and Anxiety Treatments (CANMAT) clinical guidelines for the management of major depressive disorder in adults. J Affect Disorders 117:S1-S2, 2009
75. Lengacher CA, Bennett MP, Kip KE, et al: Frequency of use of complementary and alternative medicine in women with breast cancer. Oncol Nurs Forum 29:1445-1452, 2002
76. Craske MG, Antony MM, Barlow DH: Mastery of Your Anxiety and Panic: Therapist Guide (ed 2). New York, NY, Oxford University Press, 2006
77. Craske MG, Antony MM, Barlow DH: Mastery of Your Fears and Phobias: Therapist Guide (ed 2). New York, NY, Oxford University Press, 2006
78. Zinbarg RE, Craske MG, Barlow DH: Mastery of Your Anxiety and Worry: Therapist Guide (ed 2). New York, NY, Oxford University Press, 2006
79. Foa E, Hembree E, Rothbaum BO: Prolonged Exposure Therapy for PTSD: Emotional Processing of Traumatic Experiences - Therapist Guide (ed 2). New York, NY, Oxford University Press, 2010
80. Devine EC, Westlake SK: The effects of psychoeducational care provided to adults with cancer: Meta-analysis of 116 studies. Oncol Nurs Forum 22:1369-1381, 1995
81. Sheard T, Maguire P: The effect of psychological interventions on anxiety and depression in cancer patients: Results of two meta-analyses. Br J Cancer 80:1770-1780, 1999
82. Newell SA, Sanson-Fisher RW, Savolainen NJ: Systematic review of psychological therapies for cancer patients: Overview and recommendations for future research. J Natl Cancer Inst 94:558-584, 2002
83. Osborn RL, Demoncada AC, Feuerstein M: Psychosocial interventions for depression, anxiety, and quality of life in cancer survivors: Meta-analyses. Int J Psychiatry Med 36:13-34, 2006
84. Duhamel KN, Mosher CE, Winkel G, et al: Randomized clinical trial of telephone-administered cognitive-behavioral therapy to reduce post-traumatic stress disorder and distress symptoms after hematopoietic stem-cell transplantation. J Clin Oncol 28:3754-3761, 2010
85. Bisson J, Andrew M: Psychological treatment of post-traumatic stress disorder (PTSD). Cochrane Database Syst Rev 3:CD003388, 2007
86. Gabriel GS, Lah M, Barton M, et al: Do cancer follow-up consultations create anxiety? J Psychosoc Oncol 26:17-30, 2008
87. Lofters A, Juffs HG, Pond GR, et al: "PSA-itis": Knowledge of serum prostate specific antigen and other causes of anxiety in men with metaststic prostate cancer. J Urol 168:2516-2520, 2002
88. Stark D, Kiely M, Smith A, et al: Reassurance and the anxious cancer patient. Br J Cancer 91:893-899, 2004
89. Stark D, House A: Anxiety in cancer patients. Br J Cancer 83:1261-1267, 2000
90. Greer JA, Park ER, Prigerson HG, et al: Tailoring cognitive-behavioral therapy to treat anxiety comorbid with advanced cancer. J Cogn Psychother 24:294-313, 2010
91. Roth AJ, Massie MJ: Anxiety and its management in advanced cancer. Curr Opin Support Palliat Care 1:50-56, 2007
92. Sherman AC, Pennington J, Latif U, et al: Patient preferences regarding cancer group psychotherapy interventions: A view from the inside. Psychosomatics 48:426-432, 2007
93. Holland JC, Hughes MK, Greenberg DB (eds): Quick Reference for Oncology Clinicians: The Psychiatric and Psychological Dimensions of Cancer Symptom Management. Charlottesville, VA, American Psychosocial Oncology Society, 2006
94. American Psychiatric Association: Practice Guidelines for the Treatment of Psychiatric Disorders Compendium 2006. Arlington, VA, American Psychiatric Association, 2006
95. Jin Y, Desta Z, Stearns V, et al: CYP2D6 genotype, antidepressant use, and tamoxifen metabolism during adjuvant breast cancer treatment. J Natl Cancer Inst 97:30-39, 2005
96. US Food and Drug Administration: FDA drug safety communication: Abnormal heart rhythms associated with high doses of Celexa (citalopram hydrobromide). http://www.fda.gov/Drugs/DrugSafety/ ucm269086.htm
97. Jackson KC, Lipman AG: Drug therapy for anxiety in palliative care patients. Cochrane Database Syst Rev 1:CD004596, 2004
98. Muriel AC, Hwang VS, Kornblith A, et al: Management of psychosocial distress by oncologists. Psychiatr Serv 60:1132-1134, 2009
99. National Comprehensive Cancer Network: NCCN Clinical Practice Guidelines in Oncology: Distress Management, Version 1. Fort Washington, PA, National Comprehensive Cancer Network, 2008
100. Stein MB, Cantrell CR, Sokol MC, et al: Antidepressant adherence and medical resource use among managed care patients with anxiety disorders. Psychiatr Serv 57:673-680, 2006
101. Sood N, Treglia M, Obenchain RL, et al: Determinants of antidepressant treatment outcome. Am J Manag Care 6:1327-1336, 2000
102. Schneider S, Moyer A, Knapp-Oliver S, et al: Pre-intervention distress moderates the efficacy of psychosocial treatment for cancer patients: A meta-analysis. J Behav Med 33:1-20, 2010
103. Deng GE, Cassileth BR: Integrative oncology: Complementary therapies for pain, anxiety and mood disturbance. Integrative Oncol 55:109-116, 2005
104. Sabo CE, Michael SR: The influence of personal massage with music on anxiety and side effects associated with chemotherapy. Cancer Nurs 19:283-289, 1996